JPRN-UMIN000004466已完成未知
A phase II trial of TS-1/CDDP as neoadjuvant chemotherapy against resectable gastric cancer. - A phase II trial of TS-1/CDDP as neoadjuvant chemotherapy against resectable gastric cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Metachronous or synchronous multiple cancer 2.Pregnant or in lactation. 3.Patient who is judged to be inappropriate as subject to this study by the principal investigator or the doctors in charge.
研究者
相似试验
已完成
1 期
PhaseI/II study of neoadjuvant TS-1+CDDP with concurrent radiation for biliary tract cancerBiliary tract cancerJPRN-UMIN000009028Keio University School of Medicine40
已完成
不适用
Phase II study of neoadjuvant chemotherapy of TS-1, CDDP and Paclitaxel for resectable large type 3 or type 4 gastric cancerAdvanced gastric cancerJPRN-UMIN000014332School of Medicine, Keio University40
未知
不适用
Phase II study of neoadjuvant chemotherapy TS-1/CPT-11 for advanced lower rectal cancersRectal cancersJPRN-UMIN000000962Dept. Surgery Kyoto University Hospital25
已完成
2 期
Phase II study of TS-1 chemotherapy as adjuvant treatment after resection of hepatic metastases from colorectal cancerliver metastases of colorectal cancerJPRN-UMIN000001498agoya Surgical Oncology Group60
已完成
1 期
Phase I/II trial of neoadjuvant S-1/CDDP with concurrent radiation for locally Advanced gastric cancerGastric cancerJPRN-UMIN000008941School of Medicine, Keio University52